SILVER SPRING, Md., May 5, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets for adults with heart failure with reduced ejection fraction to reduce the risk of cardiovascular death and hospitalization for heart failure. Heart...
from PR Newswire: https://ift.tt/3dlErUO
No comments:
Post a Comment